@article{Tikoo_Shukla_Chandra_Kumar_2020, title={Health Care Revolution: Ayushman Bharat }, volume={8}, url={https://ijdra.com/index.php/journal/article/view/376}, DOI={10.22270/ijdra.v8i1.376}, abstractNote={<p>India is a country with population of 133.92 Cr (2017). Due to the weak economic conditions people are unable to afford their health care thereby pushing 4.6 % of population below poverty line. It has also been noticed that three forth of Indians spend their substantial part of earning on purchasing various medicines and drugs for treatment of their ailment and other health related issues. In year 2018 there was announcement of Pradhan Mantri Jan Arogya Yojana for welfare of common masses by government of India. It covers more than 10.75 populations. Each family under scheme acts benefits insurance cover of Rs 5 Lakhs. The aim of the scheme is to provide the health care service as well as health insurance to population deprived of secondary and tertiary care service. Various government and private hospitals are empanelled under this scheme. The scheme is implemented through health and wellness centres existing over the length and breadth of country for non-communicable diseases, palliative, mental, dental, geriatric care etc. Centres are also equipped with basic medical tests. On basis of SWOT analysis conducted it has been found versatile for population. Hence scheme is going to revolutionize the health care practice prevalent in India as it increases and continue to increase access to quality health care services to the common populace of our nation.</p&gt;}, number={1}, journal={International Journal of Drug Regulatory Affairs}, author={Tikoo, Suheta and Shukla, Vikesh Kumar and Chandra, Amrish and Kumar, Ajay}, year={2020}, month={Mar.}, pages={5-10} }